Literature DB >> 29848525

Left ventricular mural thrombus despite treatment with dabigatran and clopidogrel.

Maise Fredgart1, Sabine Gill1.   

Abstract

We describe a case with severe heart failure and moderate aortic stenosis. Due to previous atrial fibrillation and ischaemic heart disease, this patient was treated with both dabigatran and clopidogrel. Despite this, a large mural thrombus was found on echocardiography. The treatment was altered to warfarin, but the thrombus did not resolve during the next eight months.Guidelines for the use of anticoagulant treatment in left ventricular thrombus are needed. Previously, a few cases presenting resistance to novel oral anticoagulants have been published and cases with thrombus formation due to dabigatran have been described. Our patient showed resistance to both dabigatran and warfarin, and there was no thrombus resolution when changing the treatment to warfarin. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cardiovascular system; heart failure; ischaemic heart disease

Mesh:

Substances:

Year:  2018        PMID: 29848525      PMCID: PMC5990090          DOI: 10.1136/bcr-2017-223899

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Prevalence of left chamber cardiac thrombi in patients with dilated left ventricle at sinus rhythm: the role of transesophageal echocardiography.

Authors:  Aurora Bakalli; Ljubica Georgievska-Ismail; Dardan Koçinaj; Nebi Musliu; Agim Krasniqi; Ejup Pllana
Journal:  J Clin Ultrasound       Date:  2012-06-22       Impact factor: 0.910

2.  Case report series of left atrial thrombus formation in patients on dabigatran therapy.

Authors:  Sanjiv Sharma; Sarabjeet Singh; Rasham Sandhu; Mark Monterroso; Neil Bhambi; Rohan Sharma
Journal:  Am J Ther       Date:  2014 May-Jun       Impact factor: 2.688

3.  The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

Authors:  Paul A Reilly; Thorsten Lehr; Sebastian Haertter; Stuart J Connolly; Salim Yusuf; John W Eikelboom; Michael D Ezekowitz; Gerhard Nehmiz; Susan Wang; Lars Wallentin
Journal:  J Am Coll Cardiol       Date:  2013-09-27       Impact factor: 24.094

Review 4.  Challenges in management of left ventricular thrombus.

Authors:  Fuad Habash; Srikanth Vallurupalli
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-06-07

5.  The vanishing vast ventricular thrombus.

Authors:  Lindsey Tilling; Harald Becher
Journal:  Eur J Echocardiogr       Date:  2006-01-19

Review 6.  Direct thrombin inhibitors.

Authors:  Catherine J Lee; Jack E Ansell
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

7.  Survival after acute necrotizing eosinophilic myocarditis complicating a massive left ventricular mural thrombus: a case report.

Authors:  Makoto Kontani; Shin-ichiro Takashima; Kiyotaka Okura; Hitoshi Takemori; Koji Maeno; Nobuyoshi Tanaka; Hirokazu Ohashi; Sakon Noriki
Journal:  J Cardiol       Date:  2007-08       Impact factor: 3.159

8.  Newly developed left ventricular apical thrombus under dabigatran treatment.

Authors:  Adem Adar; Orhan Onalan; Fahri Cakan
Journal:  Blood Coagul Fibrinolysis       Date:  2018-01       Impact factor: 1.276

Review 9.  Oral direct thrombin inhibition: a double-edged sword?

Authors:  Gabriele Fragasso; Angelo Corti; Ferdinando Loiacono; Alberto Margonato; Armando D'Angelo
Journal:  Heart Lung Vessel       Date:  2015

10.  Intra-cardiac thrombus resolution after anti-coagulation therapy with dabigatran in a patient with mid-ventricular obstructive hypertrophic cardiomyopathy: a case report.

Authors:  Bunji Kaku
Journal:  J Med Case Rep       Date:  2013-10-08
View more
  1 in total

1.  Direct Oral Anticoagulants Versus Warfarin in the Treatment of Left Ventricular Thrombus.

Authors:  Andrew Willeford; Wenhong Zhu; Craig Stevens; Isac C Thomas
Journal:  Ann Pharmacother       Date:  2020-11-15       Impact factor: 3.463

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.